VISCHER advised Polares Medical in its $40 million financing

Polares Medical, a clinical stage medical technology company focused on the development of a unique trans-catheter mitral valve hemi-replacement system to treat patients suffering from mitral regurgitation (MR), closed a $40 million financing led by Longitude Capital (Menlo Park) with the participation of Decheng Capital (Menlo Park), Endeavour Vision (Geneva), IDO Investments (Muscat), Earlybird Venture Capital (Berlin), and Wellington Partners (Munich).

The advisor

VISCHER advises Polares Medical in this transaction. The team included partner Matthias Staehelin (pictured) and associate Timothy Woodtli (both Corporate).